GSK plc (GSK) ORD GBP0.3125

- Add to watchlist
- Create an alert
- This stock can be held in a




Share news, reports & tips
-
London close: Stocks fall as China retaliates to latest US tariffs
9 April 2025 15:07
(Sharecast News) - London stocks fell sharply on Wednesday, with investors reacting to heightened geopolitical tensions after China unveiled retaliatory tariffs in response to a sweeping 104% import charge...
-
London close: Stocks slide in global reaction to Trump tariffs
3 April 2025 15:29
(Sharecast News) - London stocks closed sharply lower on Thursday as global markets reacted negatively to US president Donald Trump's unexpectedly aggressive global tariff policy announced overnight.
-
UK pharma stocks avoid selloff
3 April 2025 10:18
(Sharecast News) - GSK and AstraZeneca avoided the selloff on Thursday as pharmaceutical products were exempt from Donald's Trump's tariffs.
-
EMA accepts GSK's application to expand Nucala use
24 March 2025 07:28
(Sharecast News) - GSK said on Monday that the European Medicines Agency has accepted its application to expand the use of 'Nucala', or mepolizumab, to include patients with chronic obstructive...
-
FDA to review GSK's depemokimab
3 March 2025 09:27
(Sharecast News) - Pharmaceutical giant GSK said on Monday that the US Food and Drug Administration has agreed to review its Biologics License Application for the use of its depemokimab asset in two...
-
London close: Stocks little changed after UK data dump
21 February 2025 15:46
(Sharecast News) - London stocks closed with little direction on Friday as investors weighed fresh economic data, including signs of slowing private sector growth.
-
GSK seen as potential target for activist investors
21 February 2025 11:54
(Sharecast News) - Drugmaker GSK has been tapped as a potential target for activist investors, according to Bloomberg, which noted that shares had fallen roughly 19% since spinning off its consumer health...
-
London close: Stocks slip as US jobless claims rise
20 February 2025 16:06
(Sharecast News) - London equities ended lower on Thursday as investors reacted to a higher-than-expected rise in US jobless claims and a decline in UK consumer confidence.
-
GSK 5-in1 meningitis drug gets US approval
17 February 2025 07:04
(Sharecast News) - GSK said the US Food and Drug Administration has approved its Penmenvy drug to treat meningitis for use in individuals aged10 - 25 years.
-
GSK ups five-year sales outlook, unveils $2bn buyback
5 February 2025 07:19
(Sharecast News) - GSK's annual revenues were held back weak vaccines sales, but shares in the pharma giant jumped on Wednesday after the company unveiled plans to buy back £2bn of stock over the next...
-
GSK's pre-filled shingles vaccine accepted for review by EMA
27 January 2025 07:08
(Sharecast News) - GSK has announced that a pre-filled syringe version of its Shingrix shingles vaccine has been accepted for review by the European Medicines Agency.
-
EU regulators expand usage of GSK's Jemperli cancer drug
20 January 2025 07:22
(Sharecast News) - European regulators have expanded the usage of GSK's Jemperli drug for endometrial cancer, the pharmaceutical firm announced on Monday.
Company announcements Announcements
-
Director/PDMR Shareholding
15 April 2025 15:30
GSK
-
Transaction in Own Shares
14 April 2025 07:00
GSK
-
Director/PDMR Shareholding
11 April 2025 15:30
GSK
-
Transaction in Own Shares
11 April 2025 07:00
GSK
-
Transaction in Own Shares
10 April 2025 07:00
GSK
-
Transaction in Own Shares
9 April 2025 07:00
GSK
-
Transaction in Own Shares
8 April 2025 07:00
GSK
-
Transaction in Own Shares
7 April 2025 07:00
GSK
-
Transaction in Own Shares
4 April 2025 07:00
GSK
-
Transaction in Own Shares
3 April 2025 07:00
GSK
-
Transaction in Own Shares
2 April 2025 07:00
GSK
-
Total Voting Rights
1 April 2025 15:30
GSK
Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. This news service is operated by Digital Look Ltd. Republication or redistribution of Digital Look Ltd content, including by caching, framing or similar means, is expressly prohibited without the prior written consent of Digital Look Ltd. Please see https://www.sharecast.com/newsfeedterms/index.html for our terms and conditions.
© Digital Look Ltd 1998-2025. All rights reserved.
The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.
Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.